PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31264901-3	2020	OBJECTIVES: We tested the hypothesis that Src/epidermal growth factor receptor signaling mediates enhanced vasoconstrictor sensitivity following chronic hypoxia through NADPH oxidase-derived superoxide generation.	Superoxides	191-201	epidermal growth factor receptor	Rattus norvegicus	46-78	
9933760-5	1999	These results suggested that superoxide anion/hydrogen peroxide generated during the ischemia-reperfusion other than EGF could act as an activator for the EGFR.	Superoxides	29-45	epidermal growth factor receptor	Rattus norvegicus	155-159	
31264901-8	2020	Consistently, chronic hypoxia augmented endothelin-1-induced superoxide production through epidermal growth factor receptor signaling, and rats treated chronically with gefitinib displayed reduced right ventricular pressure and diminished arterial remodeling.	Superoxides	61-71	epidermal growth factor receptor	Rattus norvegicus	91-123	
22174146-6	2011	Similarly, an increase in superoxide anion promoted by an equipotent dose of aldosterone (10 nmol l(-1)) was blocked by spironolactone or eplerenone, by preventing epidermal growth factor receptor transactivation, but not by inhibiting glucocorticoid receptors or protein synthesis, suggesting non-genomic MR effects.	Superoxides	26-42	epidermal growth factor receptor	Rattus norvegicus	164-196	
21712088-5	2011	Furthermore, the enhanced phosphorylation of EGFR in VSMC from SHR was also restored to control levels by captopril, losartan, PP2, a c-Src inhibitor and N-acetyl-L-cysteine (NAC), superoxide anion (O(2)(-)) scavenger, whereas enhanced ERK1/2 phosphorylation was attenuated by captopril and losartan.	Superoxides	181-197	epidermal growth factor receptor	Rattus norvegicus	45-49	
21712088-5	2011	Furthermore, the enhanced phosphorylation of EGFR in VSMC from SHR was also restored to control levels by captopril, losartan, PP2, a c-Src inhibitor and N-acetyl-L-cysteine (NAC), superoxide anion (O(2)(-)) scavenger, whereas enhanced ERK1/2 phosphorylation was attenuated by captopril and losartan.	Superoxides	199-203	epidermal growth factor receptor	Rattus norvegicus	45-49